Muna Therapeutics News and Activities

View the org chart displaying its 21 main executives

Most searched biographies at Muna Therapeutics

• Michel Detheux, Chief Executive Officer
• Eileen McGuire, Director
• Rita Balice-Gordon, Independent Director

Popular executive movements at Muna Therapeutics

• Michel Detheux has joined the company as Chief Executive Officer  (posted on June 30 2026).
• Rita Balice-Gordon, Chief Executive Officer, has left the company  (posted on June 30 2026).

Create your alert
to follow the executive moves at Muna Therapeutics.

Muna Therapeutics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Muna Therapeutics

• News Details
• News Details
• News – Page 2 – Muna Therapeutics
• News – Muna Therapeutics
• News – Muna Therapeutics

Social media about Muna Therapeutics

• Muna Therapeutics on Wikipedia, Google News & Yahoo Finance
• Muna Therapeutics on LinkedIn, X (Twitter) & YouTube